BridgeBio Pharma (NASDAQ:BBIO) First Quarter 2024 Results Key Financial Results Revenue: US$211.1m (up by US$209.3m from 1Q 2023). Net loss: US$35.2m (loss narrowed by 75% from 1Q 2023). US$0.20 loss...
Source LinkBridgeBio Pharma (NASDAQ:BBIO) First Quarter 2024 Results Key Financial Results Revenue: US$211.1m (up by US$209.3m from 1Q 2023). Net loss: US$35.2m (loss narrowed by 75% from 1Q 2023). US$0.20 loss...
Source Link
Comments